Cargando…

Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors

Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qualitative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study investigates the prognostic value of volume-weighted...

Descripción completa

Detalles Bibliográficos
Autores principales: Casanova, Mafalda, Branco, Sandra, Veiga, Inês Berenguer, Barros, André, Faísca, Pedro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064533/
https://www.ncbi.nlm.nih.gov/pubmed/33576305
http://dx.doi.org/10.1177/0300985820985138
_version_ 1783682156052086784
author Casanova, Mafalda
Branco, Sandra
Veiga, Inês Berenguer
Barros, André
Faísca, Pedro
author_facet Casanova, Mafalda
Branco, Sandra
Veiga, Inês Berenguer
Barros, André
Faísca, Pedro
author_sort Casanova, Mafalda
collection PubMed
description Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qualitative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study investigates the prognostic value of volume-weighted mean nuclear volume ([Formula: see text]), a stereological estimation that provides information about nuclear size and its variability. [Formula: see text] of 55 ccMCTs was estimated using the “point-sampled intercept” method and compared with histological grade and clinical outcome. The clinical history of dogs treated with surgical excision alone was available for 30 ccMCTs. Statistical differences in [Formula: see text] were found between grade II ([Formula: see text] = 115 ± 29 µm(3)) and grade III ccMCTs ([Formula: see text] = 197 ± 63 µm(3)), as well as between low-grade ([Formula: see text] = 113 ± 28 µm(3)) and high-grade ccMCTs ([Formula: see text] = 184 ± 63 µm(3)). An optimal cutoff value of [Formula: see text] ≥ 150 µm(3) and [Formula: see text] ≥ 140 µm(3) was determined for grade III and high-grade ccMCTs, respectively. In terms of prognosis, [Formula: see text] was not able to predict the clinical outcome in 42% of the cases; however, cases with [Formula: see text] <125 µm(3) had a favorable outcome. These results indicate that, despite having limited prognostic value when used as a solitary parameter, [Formula: see text] is highly reproducible and is associated with histological grade as well as with benign behavior.
format Online
Article
Text
id pubmed-8064533
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-80645332021-05-13 Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors Casanova, Mafalda Branco, Sandra Veiga, Inês Berenguer Barros, André Faísca, Pedro Vet Pathol Oncology Canine cutaneous mast cell tumors (ccMCTs) are currently graded according to Patnaik and Kiupel grading schemes. The qualitative and semiquantitative parameters applied in these schemes may lead to inter- and intraobserver variability. This study investigates the prognostic value of volume-weighted mean nuclear volume ([Formula: see text]), a stereological estimation that provides information about nuclear size and its variability. [Formula: see text] of 55 ccMCTs was estimated using the “point-sampled intercept” method and compared with histological grade and clinical outcome. The clinical history of dogs treated with surgical excision alone was available for 30 ccMCTs. Statistical differences in [Formula: see text] were found between grade II ([Formula: see text] = 115 ± 29 µm(3)) and grade III ccMCTs ([Formula: see text] = 197 ± 63 µm(3)), as well as between low-grade ([Formula: see text] = 113 ± 28 µm(3)) and high-grade ccMCTs ([Formula: see text] = 184 ± 63 µm(3)). An optimal cutoff value of [Formula: see text] ≥ 150 µm(3) and [Formula: see text] ≥ 140 µm(3) was determined for grade III and high-grade ccMCTs, respectively. In terms of prognosis, [Formula: see text] was not able to predict the clinical outcome in 42% of the cases; however, cases with [Formula: see text] <125 µm(3) had a favorable outcome. These results indicate that, despite having limited prognostic value when used as a solitary parameter, [Formula: see text] is highly reproducible and is associated with histological grade as well as with benign behavior. SAGE Publications 2021-02-12 2021-05 /pmc/articles/PMC8064533/ /pubmed/33576305 http://dx.doi.org/10.1177/0300985820985138 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Oncology
Casanova, Mafalda
Branco, Sandra
Veiga, Inês Berenguer
Barros, André
Faísca, Pedro
Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
title Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
title_full Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
title_fullStr Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
title_full_unstemmed Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
title_short Stereology in Grading and Prognosis of Canine Cutaneous Mast Cell Tumors
title_sort stereology in grading and prognosis of canine cutaneous mast cell tumors
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8064533/
https://www.ncbi.nlm.nih.gov/pubmed/33576305
http://dx.doi.org/10.1177/0300985820985138
work_keys_str_mv AT casanovamafalda stereologyingradingandprognosisofcaninecutaneousmastcelltumors
AT brancosandra stereologyingradingandprognosisofcaninecutaneousmastcelltumors
AT veigainesberenguer stereologyingradingandprognosisofcaninecutaneousmastcelltumors
AT barrosandre stereologyingradingandprognosisofcaninecutaneousmastcelltumors
AT faiscapedro stereologyingradingandprognosisofcaninecutaneousmastcelltumors